HSPBP1 and neoplasm: When HspBP1-depleted cells were injected into mice, xenograft tumor growth and tumor size were significantly higher for BRCA1-proficient cells compared with controls over the 40-day time period of the experiments (Fig. 1C, D), but there was no difference for the BRCA1-deficient cells (Fig. 1C, D, third panel).